Silvercrest Asset Management’s GeneDx Holdings WGS Stock Holding History

Silvercrest Asset Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.91M	Buy	76,383 +14,472	+23%	+$1.32M	0.04%	430
2025 Q4	$8.05M	Buy	61,911 +121	+0.2%	+$16.6K	0.06%	363
2025 Q3	$6.66M	Sell	61,790 -31,587	-34%	-$3.44M	0.04%	385
2025 Q2	$8.62M	Buy	93,377 +22,079	+31%	+$1.73M	0.06%	342
2025 Q1	$6.31M	Sell	71,298 -411	-0.6%	-$35.7K	0.05%	371
2024 Q4	$5.51M	Buy	+71,709	New	+$5.01M	0.04%	404

Other funds holding WGS

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

ZDA

Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Silvercrest Asset Management's WGS Position: Q1 2026 in Review

Silvercrest Asset Management increased its GeneDx Holdings (WGS) stake by 23% in Q1 2026, buying an estimated $1.32M and bringing the position to 76,383 shares worth $4.91M. The position accounts for 0.04% of the portfolio, ranked #430.

Silvercrest Asset Management first reported a position in WGS in Q4 2024 and has held it in 6 quarters since. The position peaked at $8.62M in Q2 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

Silvercrest Asset Management held 76,383 shares of GeneDx Holdings worth $4.91M as of Q1 2026.
Silvercrest Asset Management bought 14,472 GeneDx Holdings shares in Q1 2026, an estimated $1.32M.
GeneDx Holdings made up 0.04% of Silvercrest Asset Management's portfolio in Q1 2026, its #430 holding.
Silvercrest Asset Management first reported a position in GeneDx Holdings in Q4 2024 and has held it in 6 quarters since.
Silvercrest Asset Management's GeneDx Holdings position peaked at $8.62M in Q2 2025.
240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Silvercrest Asset Management's 13F filing for Q1 2026, filed 15 May 2026.